Hims & Hers Health, Inc. (HIMS) vs Lantheus Holdings, Inc. (LNTH)
Hims & Hers Health, Inc. and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. and Lantheus Holdings, Inc. are of similar size ($6.9B and $6.5B). Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Lantheus Holdings, Inc. trades at 23.7×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 2.35%. Lantheus Holdings, Inc. has the higher net margin (17.7% vs −5.51%) and the higher return on invested capital (14.7% vs −11.4%). Across the 19 metrics below, Lantheus Holdings, Inc. leads on 13 and Hims & Hers Health, Inc. on 6.
Valuation
Profitability
| Metric | HIMS | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 60.14% | 53.94% |
| Operating margin | (5.99%) | 19.43% | 0.00% |
| Net margin | (5.51%) | 17.69% | 0.00% |
| Free cash flow margin | 3.22% | 25.24% | 0.00% |
| Return on equity | (32.03%) | 22.21% | (0.40%) |
| Return on assets | (5.16%) | 12.15% | (3.32%) |
| Return on invested capital | (11.38%) | 14.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack